18:40 ยท 7 October 2026

Large decline in crude inventories ๐Ÿ›ข๏ธ๐Ÿ“‰

16:30 - Crude Oil and Distillate Inventories (Weekly) [DOE]:

  • Crude oil inventories: -3.186M (Expected: 1.9M; Previous: 0.922M)
  • Crude oil imports: -0.053M (Previous: -0.468M)
  • Gasoline: 0.382M (Expected: -1.700M; Previous: -1.684M)
  • Gasoline production: -0.117M (Previous: -0.124M)

The report is a significant surprise and a positive price signal for crude oil. Commercial crude oil inventories fell by 3.2 million barrels, while the market expected an increase of 1.9 million. This implies a surprise of about 5.1 million barrels versus consensus.

The release is much weaker for refined products and crack spreads. Instead of the expected drop in gasoline inventories, gasoline posted an increase, and distillates declined only marginally. Alongside rising distillate production and higher refinery utilization, this suggests refineries are increasing product supply faster than the market is absorbing it.

Oil prices are limiting their reaction to the release, down by around 0.3%.

OIL (M5)

 

Source: xStation5

8 October 2026, 15:13

Market Wrap: A 4% surge in oil prices weighs on indices (08.10.2026)

8 October 2026, 13:42

EURUSD falls below 1.12 amid hawkish Fed's Waller remarks

8 October 2026, 10:55

Chart of the Day ๐Ÿ“‰ DE40 Falls 0.7% and Tests Key Support Amid Weak European Market Sentiment (October 8, 2026)

8 October 2026, 10:40

Economic Calendar: U.S. Jobless Claims and ECB Meeting Minutes in Focus (08.10.2026)

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.